Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells

Author:

Grieco Paolo,Franco Renato,Bozzuto Giuseppina,Toccacieli Laura,Sgambato Alessandro,Marra Monica,Zappavigna Silvia,Migaldi Mario,Rossi Giulio,Striano Stefano,Marra Luigi,Gallo Luigi,Cittadini Achille,Botti Gerardo,Novellino Ettore,Molinari Agnese,Budillon Alfredo,Caraglia Michele

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference44 articles.

1. 20-Year outcomes following conservative management of clinically localized prostate cancer;Albertsen;JAMA,2005

2. A rapid in vitro assay for quantitating the invasive potential of tumor cells;Albini;Cancer Res,1987

3. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14;Ames;Nature,1999

4. Effect of endothelin-1 as growth factor on a human glioma cell line, its characteristic promotion of DNA synthesis;Asano;J Neurooncol,1984

5. Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity;Bachmeier;Anticancer Res,2001

Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3